Nassim Usman, Director at GYRE THERAPEUTICS, INC. (GYRE), sold 40,000 shares at $17.26 ($690K) on 2024-03-15, disclosed to the SEC on 2024-03-19.
Scheduled sale ($690k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.26 | 20,000 | $345K | 50.0% |
| 2 | $17.26 | 20,000 | $345K | 50.0% |
| Total | $17.26 avg | 40,000 | $690K | 100% |
| Filing → |
| GYRE | SELL | 2024-04-03 | $323K | — | Filing → |
| CBIO | BUY | 2022-08-10 | $2K | — | Filing → |
| CBIO | BUY | 2022-02-16 | $1K | — | Filing → |